MEDICATION ABORTION  
  evidence-based information about mifepristone, methotrexate & misoprostol
 

home questions

legal status of abortion worldwide

references

links

 

Vous pouvez aussi lire cette page en français; Puede leer esta pagina in español;  
You can read this page in Arabic
You can read this website in Persian

How does medication abortion work?

Regimen or procedure
Mechanism of action
Advantages
Disadvantages

Mifepristone and misoprostol

Mifepristone is taken orally and blocks the action of progesterone. This results in:

  1. Uterine lining thinning
  2. Pregnancy detachment
  3. Cervical softening and dilation
  4. Uterine contractions

Subsequent administration of buccal, sublingual, or vaginal misoprostol, a prostaglandin E1analogue, results in uterine contractions and expulsion of the products of conception.

  • High success rate (95%-98%)
  • Very effective during early pregnancy (through nine weeks' LMP)
  • For many women, the process resembles a heavy period
  • For many women, the experience is considered more "private"
  • Usually avoids surgical intervention
  • Anesthesia not required
  • Can sometimes be obtained through telemedicine services
  • May take days or occasionally weeks for the abortion to complete
  • Efficacy decreases at later gestational ages
  • Bleeding may continue for several weeks after the abortion is complete
  • Women may see blood clots and the products of conception
  • Sometimes requires multiple clinic visits
  • Mifepristone can be expensive
  • Mifepristone is not available in many countries

Methotrexate and misoprostol

Methotrexate is an anti-metabolite that inhibits DNA synthesis. Given by injection or taken orally, methotrexate interferes with the implantation process.

Subsequent administration of oral or vaginal misoprostol, a prostaglandin E1 analogue, results in uterine contractions and expulsion of the products of conception.

  • High success rate (95%) if used in the first seven weeks of pregnancy
  • For many women, the experience is considered more "private"
  • Usually avoids aspiration intervention
  • Anesthesia not required
  • Treats ectopic pregnancy
  • Requires at least two clinic visits
  • Often takes longer than the mifepristone and misoprostol regimen
  • Efficacy decreases significantly after 7 weeks gestation
  • Post-procedure bleeding may last for weeks
  • Women may see blood clots and the products of conception

Misoprostol alone

Misoprostol is a prostaglandin E 1 analogue that causes uterine contractions and cervical softening. Administration of buccal, sublingual, vaginal misoprostol alone results in uterine contractions and expulsion of the products of conception.

  • Used during early pregnancy  (through nine weeks)
  • For many women, the process resembles a heavy period
  • For many women, the experience is considered more "private"
  • Usually avoids aspiration intervention
  • Anesthesia not required
  • Available in many more countries than either mifepristone or methotrexate
  • Often much cheaper than other medication abortion methods
  • May be available directly from pharmacies
  • Success rate is low (75%-85%) compared to other medication abortion regimens
  • Often takes days to weeks to complete
  • Cramping and bleeding more significant than other medication abortion regimen
  • Post-procedure bleeding my last for weeks
  • Women may see blood clots and the products of conception

Vacuum aspiration procedures

A straw-like tube (a cannula), which is attached to a suction apparatus is inserted into the uterus through the open (dilated) cervix. The uterine contents are then emptied by suction.

  • Very high success rate (>99%)
  • Often requires only one clinic visit
  • Procedure completed within minutes
  • Sedation is available
  • Involves instrumentation and a procedure
  • Requires an in-person interaction with a clinician
  • Often considered to be less "private"
  • May not be widely available
 

If you have questions about medication abortion, please visit our frequently asked questions section

Your access and use of this website is subject to certain terms of use. By viewing web pages in this site, you accept, without limitation or qualification, these terms. Read our privacy statement. Last updated January 2015.